gd T cells are unconventional lymphocytes commonly described as 'innate-like' in function, which can respond in both a T cell receptor (TCR)-independent and also major histocompatibility complex (MHC)-unrestricted TCR-dependent manner. While the relative importance of TCR recognition had remained unclear, recent studies revealed that human Vd1 T cells display unexpected parallels with adaptive ab T cells. Vd1 T cells undergo profound and highly focussed clonal expansion from an initially diverse and private TCR repertoire, most likely in response to specific immune challenges. Concomitantly, they differentiate from a Vd1 T cell naïve (T naïve ) to a Vd1 T cell effector (T effector ) phenotype, marked by the downregulation of lymphoid homing receptors and upregulation of peripheral homing receptors and effector markers. This suggests that an adaptive paradigm applies to Vd1 T cells, likely involving TCR-dependent but MHC-unrestricted responses to microbial and non-microbial challenges.
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gd T Cells and the Lymphoid Stress Surveillance Hypothesis gd T cells have coevolved alongside ab T cells and B cells for at least the past $450 million years of vertebrate evolution [1, 2] , each distinguished by related but distinct somatically recombined antigen receptors. However, our understanding of these different lineages is strikingly imbalanced. Critical to our understanding of ab T cell and B cells is the classical adaptive paradigm (Box 1). Within this, seminal discoveries have established the core function of the ab T cell lineage: to enable immune responses to target cells based on the presence on their surface of antigenic peptide in the context of MHC molecules; similarly, we understand that B cells, which underpin humoral immunity, enable the production of soluble antibodies capable of recognising a diverse range of antigenic targets in native, 3D conformation. In keeping with Burnet's suggestion that 'receptor occupation' is key in driving the activation and clonal selection of adaptive lymphocytes [3] , structural studies have confirmed both the involvement of clonotypically unique hypervariable loops in ab TCR/peptide-MHC and B cell receptor (BCR)/antigen engagement, and the significance of such interactions in regulating multiple facets of their immunobiology (Box 1).
Originally identified serendipitously during studies defining ab TCR genes [4, 5] gd T cells have by contrast remained somewhat mysterious both in terms of the immunological niche they occupy and the key reason(s) for their evolutionary preservation as a third lymphocyte lineage within vertebrate immunity. Moreover, although gd T cells are implicated in a range of immune settings, including antimicrobial immunity, antitumour immunity, and tissue homeostasis (reviewed in [6] ), the central paradigms that govern their development and antigen recognition functions are unresolved. Finally, despite remaining a focus of ongoing interest, the closely related issue of the importance and exact role of gd TCR occupation in gd T cell biology remains a central question. Vd1 T cells are the predominant tissueassociated gd T cell subset in humans, and can recognise signs of cellular dysregulation, including viral infection and transformation. They are often assumed to be innate-like effectors.
The Vd1 TCR repertoire is initially diverse, yet a few clonotypes typically expand heavily over time. Such expanded clonotypes are diverse in sequence both within and between individuals.
Clonal expansion occurs concurrently with differentiation from Vd1 T naïve to Vd1 T effector status, alongside a switch from lymphoid to peripheral homing receptors, and upregulation of cytotoxic pathways.
This concurrent expansion and differentiation suggests an adaptive-like response, likely driven by diverse stimuli, including microbial pathogen infection.
One concept emerging from mouse studies of gd T cells is that certain gd T cell subsets, instead of functioning via conventional adaptive paradigms, may instead act as 'innate-like' lymphocytes. Notably, murine gd T cells express distinct TCRg and TCRd combinations at different anatomical sites, and often display semi-invariant TCR repertoires, in some cases featuring highly restricted CDR3 regions [7] [8] [9] . They can be preprogrammed during thymic development to differentiate into discrete effector populations producing either interleukin-17 (IL-17) or interferon-gamma (IFN-g) [10, 11] . More recently, intra-epithelial lymphocyte populations have been shown to be selected in tissues after birth, dependent on the expression of particular butyrophilin-like molecules (BTNLs) [12] . Such populations of 'activated-but-resting' unconventional lymphocytes are thought to be capable of reacting directly to dysregulated target cells without the need for clonal expansion and differentiation. These data align with the idea such subsets may recognise a limited range of host-encoded stress ligands [13] , and suggest that their TCRs act like surrogate pattern recognition receptors (PRRs) for molecular signals of microbial/non-microbial stress. In humans, the gd T cell subset that aligns most clearly to this biology is characterised by a Vg9/Vd2 chain pairing, and represents the predominant peripheral blood subset (1-10% of T cells) [14] . Based on their restricted TCR Vg and Vd gene segment usage and CDR3 lengths, presence of common CDR3 motifs, foetal generation, polyclonal production of IFNg and Tumour Necrosis Factor-a (TNFa) following exposure to pyrophosphate antigens (P-Ags), and strong dependency of TCR-mediated recognition on the BTN3A1 Ig-like protein, this subset arguably conforms to such an innate-like functional paradigm, although the exact mechanisms underlying its recognition of target cells remain unclear. To some extent, the features of these gd T cell subsets mirror those of unconventional ab T cell subsets [e.g., mucosal-associated invariant T cells (MAITs) and invariant natural killer cells 
Generation of a Diverse Antigen Receptor Repertoire and Tolerance Mechanisms
Both ab T cell and B cell lineages feature somatically recombined TCRs and BCRs, with repertoires featuring high diversity in their hypervariable complementarity-determining region loops, particularly CDR3. For both lineages, selection events during lymphocyte development are critical for immune tolerance. ab T cells undergo positive and negative selection in the thymus; B cells, in the bone marrow, undergo both antigen-independent positive selection, based on tonic BCR signalling, and processes that eliminate or mitigate autoreactive specificities, including negative selection and anergy induction.
Clonal Expansion from a Diverse Immune Receptor Repertoire
The selection of individual clonotypes from within the diverse naïve immune receptor repertoire allows expansion of specific ab T cell and B cell clonotypes bearing receptors that critically enable amplified responses to specific immune challenges, such as pathogen infection.
Differentiation into Long-Lived Effectors
Concurrent with clonal expansion, both ab T cell and B cell lineages not only undergo differentiation to effectors, but also permit the maintenance of long-lived clonotypically expanded populations, enabling immunological memory, whereby faster and more potent immune responses are induced in response to secondary antigenic challenge.
Critical Importance of Antigen Receptor-Ligand Interactions
Diverse studies highlight the central role for TCR-pMHC and BCR-ligand interactions in directing ab T cell and B cell development, maintenance, clonal amplification and activation, and memory formation, emphatically validating the concept that 'receptor occupancy' is a central driver of adaptive lymphocyte biology.
(iNKTs)], which also feature highly restricted TCR repertoires [15, 16] , and have been shown to recognise relatively nonpolymorphic ligands [MHC class I-related gene protein (MR1) and Cluster of differentiation 1 (CD1), respectively].
These observations led to the development of the lymphoid stress surveillance hypothesis [17] , which postulates that such effectors, by circumventing the requirement for clonal selection and differentiation, may provide protection from microbial or non-microbial stress challenges during the initial phase of the response, before adaptive immune responses have been generated.
A key finding in this area has been that such subsets can be activated not only via their TCR, but also independently by TCR-extrinsic signals. For example, mouse dendritic epidermal T cells (DETC, a subset of gd T cells present in murine skin) can be activated directly via NK receptor (NKR)-mediated recognition of stress ligands expressed on stressed epithelium, independently of the TCR [18] . Moreover, while human Vg9/Vd2 T cells exhibit potent TCR-dependent recognition of P-Ag-exposed target cells, they can also be activated by NKG2D-ligand interactions and are responsive to cytokines such as IL-12/IL-18 [19] [20] [21] . In addition, recent studies on mouse skin and gut gd T cell subsets suggest that TCR signals, potentially mediated via interactions with BTNLs, are required for the development, homing, and establishment of their effector program [11, 12] ; however, these cells can become hyporesponsive to TCR signals and function in an TCR-independent manner to respond to signs of cellular stress [22] .
In addition to Vg9/Vd2 T cells, a second human gd T cell compartment exists, bearing Vd2-negative TCRs, of which the Vd1 component is dominant. Vd1 T cells are the most prevalent subtype of gd T cells at birth [23] , and the dominant gd T cell subtype in peripheral tissues in adults, such as the gut [24, 25] and skin [26] . Vd1 T cells have remained very much an enigma in terms of the fundamental paradigms underlying their biology. Based on their predominant effector phenotype, their potent cytotoxicity/cytokine production, combined with their ability to recognise both virally infected and also cancerous cells, and their expression of NKRs [27] [28] [29] , they have often been assumed to act in an innate-like fashion, similar to NK cells, potentially enabling recognition of diverse cellular stress signals in target cells. However, here we review recent data that have revised this picture, and suggest instead that Vd1 T cells exhibit a radical new adaptive immunobiology. These data highlight some of the most significant questions in gd T cell biology, including the importance and exact role of the gd TCR that defines the lineage, but ironically, is so poorly understood.
TCR Repertoire Analyses Reveal Vd1 T Cell Clonal Amplification
The advent of next-generation sequencing (NGS) approaches has allowed in-depth analyses of the TCR/BCR repertoire within the ab and B cell lineage, respectively [30, 31] . Furthermore, application of these technologies to human peripheral blood gd T cells has provided valuable information on clonal evolution within the gd T cell lineage. The approaches used include either DNA-based or RNA-based methods, with the former highlighting the requirement to purify gd T cells from ab subsets to avoid contamination of TCRg sequences recombined in mature ab T cells [32] . One inherent challenge of these methods is the potential for polymerase chain reaction (PCR) and sequence errors [33] . In the absence of in silico error correction and appropriate data handling, this can result in retention of erroneous sequences, often resulting from single-base errors of other higher frequency clonotypes. Therefore, caution should be applied when interpreting highly similar TCR base sequences. The availability of public software packages dedicated to the interpretation of NGS TCR sequencing data (MiTCR [34] , MiXCR [35] , and TcR [36] ), which provide robust error correction, should alleviate such challenges. Moreover, since RNA-based approaches are potentially vulnerable to bias, based on the overall level of RNA differing between cells in different activation and/or differentiation states, ideally parallel techniques, such as single-cell PCR-based TCR analysis, should be considered to validate NGS-based TCR frequencies correlate with cell number on a specific platform [37] [38] [39] .
Such studies have not only shed substantial light on Vd1 T cell immunobiology, but equally importantly, have also highlighted features of the Vd1 repertoire that contrast markedly with that of both peripheral blood Vg9/Vd2 T cells and thymically programmed mouse gd T cells. First, based on analyses of cord blood samples, the Vd1 TCR repertoire at the start of life, which features a variety of Vg chain pairings, is clonotypically diverse, featuring a range of CDR3 lengths apparently unrelated in sequence. Importantly, these neonatal cord blood Vd1
+ repertoires are essentially entirely unfocussed: in other words, it appears that 'all clonotypes are created equal', with no single sequence exceeding 1-2% of the repertoire ( Figure 1 ). This contrasts with the Vg9/Vd2 population, which, even in foetal and cord blood, includes relatively prevalent Vg9-JgP clonotypes that are public (i.e., shared at either the nucleotide or amino acid level between individuals) and are present throughout life, consistent with selection of a semi-invariant repertoire preprogrammed in development for polyclonal P-Ag recognition [32, [40] [41] [42] .
A second important finding from such studies is that, in comparison to cord blood repertoires, adult Vd1 repertoires are in general substantially more focussed, typically resulting from the presence of a relatively small number (e.g., <5) of heavily expanded clonotypes, and which often account for a large proportion of the total adult Vd1 repertoire. Of note, parallel single-cell TCR analysis was used by Davey et al. [38] and Ravens et al. [39] to confirm that these represented genuine numerical clonal expansions, and were not biased by RNA abundance. Strikingly, both adult and cord blood Vd1 + TCR repertoires were overwhelmingly private (i.e., unique to an individual at both a nucleotide and amino acid level; even more so than TCRb [38] ), with the Complementarity determining region 3 (CDR3) lengths of expanded clonotypes highly diverse, and their sequences apparently unrelated, both within and between individuals [38] . These features appeared to stem from the addition of high levels of nontemplated (N) nucleotides (introduced by terminal deoxynucleotidyl transferase) or occasionally palindromic (P) nucleotides (a mean of 19 N/P nucleotides for Vd1 CDR3) during variable (diversity) joining [V (D)J] recombination. Both the private nature of the Vd1 repertoire and the presence of such dominant clonal expansions contrast markedly with the Vg9/Vd2 TCR repertoire, which displays less pronounced focussing and contains several public Vg9 sequences in cord blood and adults [32, 38, 41] . Moreover, compared with Vd1 T cells, the Vg9/Vd2 T cell repertoire features restricted CDR3g and CDR3d lengths, with CDR3d2 sequences generally considerably shorter than CDR3d1 sequences. Similarly, TCRab repertoires also display CDR3 length restriction, which is likely imposed by the structural constraints of peptide-MHC recognition [43] .
gd TCR repertoire analyses have also highlighted factors driving such clonal expansions. In particular, Ravens et al. showed that acute cytomegalovirus (CMV) infection following stem cell transplantation (SCT) can drive expansion of Vd2 neg (predominantly Vd1) TCR clonotypes [39] ;
Vd repertoires were also noted to be private. These findings build on numerous studies highlighting the importance of Vd2-negative T cells in responses to CMV infection following kidney transplantation and in healthy donors [29, 44, 45] , including spectratyping data consistent with a degree of clonotypic focussing in CMV pos healthy donors [29] . Despite this, the link to CMV infection is not necessarily straightforward, because both Ravens et al. [39] and Davey et al. [38] noted that the Vd1 repertoire of some CMV pos individuals lacked clonal expansions, indicating that Vd1 + TCR clonal expansion was not an inevitable consequence of CMV infection ( Figure 1 ). The reason for this is unclear, but could conceivably reflect different routes of infection, greater/lesser dependency of the anti-CMV response on Vd2 neg Vd1 neg gd T cells, and/or the presence of 'holes' in the Vd1 TCR repertoire in some individuals. Further studies are required to address these possibilities. Moreover, several CMV neg individuals also had heavily expanded Vd1 clonotypes, indicating that CMV infection is not the sole immune challenge that stimulates Vd1 T cell responses ( Figure 1 ). Consistent with diverse stimuli for the Vd1 subset, expansion of Vd1 T cells has also been noted in response to HIV [46] and in synovial fluid in Lyme disease [47] , while two case reports describe Vd1 clonal focussing after EBV infection in SCT [48, 49] . Nevertheless, infectious stimuli underlying clonotypic focussing in healthy donors, other than CMV, remain to be identified. Finally, irrespective of the stimuli inducing such responses, both Davey et al. [38] and Ravens et al. [39] provide evidence that such expanded clonotypes can be long-lived, and persist for at least 2 years, consistent with long-term contributions to immunosurveillance.
Clonal Selection in Vd1 T Cells Induces Adaptive Changes in Phenotype and Function
Davey et al. [38] combined NGS TCR sequencing, single-cell TCR analyses, and a flow cytometric immunophenotyping approach to delineate different Vd1 subsets in adult peripheral blood and cord blood samples. Notably, a naïve-like CD27 hi Vd1 subset was identified expressing highly diverse TCRs and multiple markers common to naïve T cells, including IL-7R, CD28, CD62L, and CCR7 ( Figure 2) ; we hereafter apply the term 'Vd1 T naïve ' to this subset. Importantly, although such T naïve cells were typically a minor fraction of adult peripheral blood Vd1 T cells, essentially the entire Vd1 T cell subset in cord blood was clonotypically unfocussed. By contrast, clonotypically expanded Vd1 TCRs present in adults invariably resided within a differentiated effector CD27 lo/neg compartment largely absent in cord blood, which was detected to different extents within adult peripheral blood Vd1 T cells across a 20-person cohort. This compartment shared several phenotypic features with conventional Teffector populations, including expression of granzymes, perforin, and CX3C chemokine receptor 1 (CX 3 CR1; Figure 2) ; we hereafter apply the term 'Vd1 T effector ' to this subset. Importantly, the observation that the Vd1 compartment of the minority of adult donors who retained relatively diverse Vd1 TCR repertoires was dominated by Vd1 T naïve cells confirmed the validity of this phenotypic distinction, and highlighted that clonal expansion and differentiation were not inevitable consequences of Vd1 T cell maturation.
These phenotypic features of Vd1 T naïve and T effector subsets point towards an adaptive biology. First, the transition from Vd1 T naïve to T effector subset is accompanied by a reprogramming of homing receptor expression. Vd1 T naïve cells uniformly express high levels of central lymphoid homing markers. By contrast, Vd1 T effector cells exhibit strong downregulation of CCR7 and CD62L, but increased CX 3 CR1, which binds to fractalkine, an endothelial homing chemokine. The respective expression profiles of these markers on Vd1 T naïve and T effector subsets closely mirrored expression on CD8 naïve and T EMRA cell populations, respectively. Correspondingly, and as suggested for CX 3 CR1 hi CD8 memory T effector cells [50] , CX 3 CR1 hi Vd1 T effector cells may be involved in endothelial immunosurveillance. In terms of function, whereas Vd1 T naïve cells, such as naïve CD8 T cells, were devoid of cytotoxic effector markers (e.g., perforin, and granzymes A and B), these were heavily upregulated in Vd1 T effector cells (equivalent to CD8 T EMRA populations). Moreover, Vd1 T effector cells retained a rapid proliferative capacity and TCR Vd1 T cells also displayed markers and functional responses consistent with naïve and effector T cells, respectively. Vd1 T naïve cells, alongside a broad gd TCR repertoire, expressed the co-stimulatory receptor CD28, lymphoid tissue homing receptor CCR7, tissue access molecule CD62L, and mounted a proliferative response to the lymphoid tissue-associated homeostatic cytokine interleukin 7 (IL-7). By contrast, Vd1 T effector cells had downregulated CD28, CCR7, CD62L, and IL7Ra and upregulated cytotoxic granzymes, perforin, and endothelial homing receptor CX3C chemokine receptor 1 (CX 3 CR1), and proliferated in response to the peripheral tissue-associated cytokine IL-15. Both populations were unresponsive to innate stimuli (IL-12 and IL-18) but retained TCR responsiveness (anti-CD3 stimulation), with Vd1 T effector cells becoming rapidly activated, whereas Vd1 T naïve cells responded over a longer period of time.
sensitivity, and were preferentially sensitive to IL-15 relative to Vd1 T naïve cells, which conversely (and similar to naïve CD8 T cells) were preferentially responsive to IL-7 and exhibited slower proliferation following TCR stimulation. These findings strongly suggest that the TCR-diverse CD27 hi and highly TCR focussed CD27 lo/neg populations represent bona fide naïve and effector Vd1 subsets, respectively (Figures 2 and 3 ).
These findings demonstrate that, far from representing a preformed effector subset from birth, Vd1 T cells are initially highly naïve in phenotype and feature an entirely unfocussed TCR repertoire. They also suggest that differentiation to an effector phenotype is not an inevitable developmental process, but is inextricably linked to clonal amplification, and drastically affects both cytotoxic capability and homing receptor expression (Figure 3 ).
Adaptive MHC-Unrestricted gd T Cell Stress Surveillance: A Paradigm for Vd1 T Cells
The observations outlined above highlight surprising parallels between Vd1 T cells and classical adaptive T cell subsets, particularly CD8 T cells; conversely, they emphasise key distinctions between Vd1 T cells and the Vg9/Vd2 T cell subset. They suggest that the gd TCR is central to the biology of Vd1 T cells, and lead us to suggest a previously unrecognised mode of MHCunrestricted adaptive immunobiology applies to the Vd1 T cell subset (Box 2). This paradigm and the evidence that underpins it, has several implications worthy of consideration that will likely frame future investigations.
Tolerance Induction The Vd1 and Vg9/Vd2 T cell subsets develop at different stages, consistent with a distinct underlying immunobiology and TCR repertoire for the two compartments. Vg9/Vd2 T cells are generated during development in the foetal liver, and later the foetal thymus, and are only present in small numbers in the postnatal thymus [51, 52] . Development may require positive selection for BTN3A1 reactivity and/or self phosphoantigens, such as isopentenyl pyrophosphate (IPP), and subsequent expansion after microbial exposure during early childhood [53] . By contrast, Vd1 T cells are the dominant gd T cell population in the postnatal thymus. It is unclear whether human gd T cells undergo thymic selection. The diversity of CDR3 lengths and sequences for Vd1 and associated Vg TCR chains would suggest a strong potential for autoreactivity; however, there is little evidence of negative selection in gd T cells [32] . Alternatively, peripheral tolerance mechanisms may be involved in deleting or inducing the anergy of strongly autoreactive cells, or other mechanisms similar to NK licensing or arming (reviewed in [54] ) may be used to set thresholds for Vd1 reactivity. Vd2 neg gd T cells express inhibitory NKRs, such as LILRB1/ILT2, which may be involved in this process [28] . Additionally, TCR selfreactivity may involve low-affinity TCR-ligand interactions and may require additional costimulatory signals or adhesion molecules to lead to productive TCR signalling [55] .
T Cell Priming and Migration
Although the cellular mechanisms underlying initiation of Vd1 clonal expansions are unclear, the immune phenotype of Vd1 T naïve cells suggests preferential access to secondary lymphoid organs, as opposed to clonally expanded Vd1 T effector subsets. This implies that Vd1 T naïve cells most likely recirculate between blood and lymph tissues (Figure 3) , and suggests that clonal amplification requires lymphoid tissue-derived factors and/or is initiated during a priming step in secondary (or possibly tertiary) lymphoid organs. Future studies assessing the differentiation status and localisation of Vd1 T cells in secondary and/or tertiary lymphoid organs will be required to address these suggestions, and may shed light on whether specific antigenpresenting cell types are involved in priming. Conversely, the increased expression of CX 3 CR1 on Vd1 T effector populations and their enhanced sensitivity to IL-15 suggests that they preferentially home to solid tissues, and contribute to a more clonotypically focussed repertoire at such sites. Further studies comparing the phenotypic features and TCR diversity of peripheral blood Vd1 T cells with those in solid tissues will address these issues.
Box 2. Key Principles of Adaptive Stress Surveillance
We propose that three key tenets of an adaptive immunobiology apply to Vd1 T cells. We suggest that:
(i) specific stress stimuli, including microbial infection and/or colonisation, are capable of triggering the clonal expansion and differentiation of Vd1 T effector clonotypes from a highly diverse, unfocussed Vd1 T naïve pool;
(ii) as for ab T cells and B cells, 'receptor occupancy', in this context the ability of the Vd1 gd TCR to engage cognate ligands, drives clonal expansion and initiates differentiation to the effector state; and (iii) clonally expanded Vd1 T effector populations, which are relatively long-lived, provide enhanced protection against recurrent immune challenges. Mechanisms and Targets Underpinning Vd1 gd TCR Ligand Recognition Defining the ligands recognised by the gd TCR remains a major goal and one that may help unlock the molecular basis by which gd T cells recognise abnormal target cells (Table 1) .
Most gd TCR ligand investigations have focussed on peripheral blood populations. Importantly, our understanding of the Vd1 TCR repertoire in solid tissues is limited. However, a recent study highlighted a Vg4Vd1 subpopulation, present at variable frequencies in colorectal tissue in different individuals, which underwent TCR-dependent activation in response to BTNL3/8-positive target cells [12] . A priority for future investigations is to understand whether BTNL3/8 act as direct ligands for this Vg4Vd1 subpopulation, and whether the TCR repertoire and phenotype of such cells reflect a semi-invariant innate-like paradigm or an adaptive immunobiology. In addition, a more comprehensive understanding of the Vd1 TCR repertoire in different solid tissues is required.
Current data on peripheral blood Vd1 T cells indicate a highly diverse TCR repertoire both in terms of Vg chain pairing and Vd1/Vg CDR3 regions. Notably, there are no obvious similarities in the CDR3 regions of clonally amplified Vd1 TCRs, either in terms of lengths or sequences. Moreover, these features may apply to other Vd2-negative TCRs [38] . The high degree of CDR3 diversity within the Vd1 TCR repertoire, including use of diverse Vg gene segments, contrasts markedly with other unconventional T cell populations thought to recognise single germlineencoded ligands (e.g., iNKTs [15] , MAITs [16] , and Vg9/Vd2 T cells [38, 39] ), which feature semiinvariant TCR repertoires, including prominent public CDR3 clonotypes; by contrast, the Vd1 TCR repertoire is both diverse and essentially private [38, 39] .
Importantly, the high diversity of the peripheral blood Vd1 TCR repertoire, including in expanded clonotypes, may not necessarily exclude recognition of a limited range of physiologically relevant ligands shared between individuals. Of note, there is precedent for degeneracy in ab TCR recognition, whereby the same peptide-MHC complex can be recognised by TCRs of diverse sequence [56] . Similarly, antibodies featuring diverse CDR loops can recognise the same protein antigen, either via distinct or similar surface epitopes [57, 58] . However, an alternative, and possibly more likely scenario, is that the high Vd1 TCR diversity reflects a diversity of ligands recognised. This is arguably supported by the diverse array of ligands proposed for Vd2-negative TCRs [55, [59] [60] [61] [62] (Table 1) . A major challenge is to make sense of this seemingly unrelated group of ligands and decipher key underlying principles; however, the basis for making such judgements has hitherto remained entirely unclear. Based on the central assumption that TCR-ligand binding ('receptor occupation') drives clonal expansion, the adaptive paradigm we outline suggests a set of criteria (based on clonotype frequency, phenotype, CDR3 involvement, and ligand expression pattern; Table 1 ) by which the position of candidate ligands within this adaptive framework could be assessed.
Re-evaluation of current gd T cell ligands in light of these criteria prompts several observations. Since reactivities to CD1c [60] and CD1d [61, 63, 64] described to date reflected extremely low percentages of the Vd1 T cell repertoire (contributing <0.05% and <0.16% of total T cells, respectively; Table 1 ), they are unlikely to represent in vivo expanded Vd1 T effector clonotypes. However, they could derive from Vd1 T naïve subsets, and conceivably changes in lipid cargo in different physiological settings may drive TCR-mediated Vd1 clonal expansions. Similarly, phycoerythrin (PE) [62] , a model BCR antigen derived from a marine alga, was also convincingly demonstrated to be a direct gd TCR ligand in mice, and for an extremely low proportion of the human Vd1 T cell repertoire (<0.025% of CD3 + T cells, One human gd TCR reactivity, to Endothelial Protein C Receptor (EPCR) [55] , arguably fulfils the criteria for recognition by an expanded Vd1 T effector clonotype, albeit involving a Vd5 TCR (Table 1 ). In addition, the LES TCR that recognised EPCR was a private TCR sequence, in keeping with the properties of Vd1 TCRs and the finding that recognition of EPCR was restricted to a single patient. Despite this, it enabled gd TCR and EPCR-mediated recognition of CMV-infected fibroblast and/or endothelial cells. Interestingly, although EPCR expression was not enhanced by CMV infection, LES gd T cell activation was dependent on a TCRextrinsic 'multimolecular stress signature', which included induction of increased expression of intercellular adhesion molecule 1 (ICAM-1) on target cells after CMV infection [55] . Moreover, while similar changes were evident in some tumour lines, it is also clear that overexpression of EPCR itself is linked to genetic changes during tumourigenesis [65] , and has also been linked to chemoresistance [66] . Conceivably, the dependence of effector function on TCR-extrinsic changes in addition to the presence of TCR ligands could be an important factor in the maintenance of gd T cell tolerance in the absence of relevant microbial and/or non-microbial stress stimuli. If, as previously suggested, the LES-EPCR reactivity proves to be 'unique but paradigmatic', then other private ligands may map onto other private expanded clonotypes. A repertoire-based ligand identification strategy, ideally focussing on multiple gd TCR specificities expanded in response to a single immune challenge, should confirm this, and may reveal commonalities between ligands (e.g., expression on a particular tissue relevant to the specific pathogen infection). In addition, other modes of stress stimulusinduced gd TCR-ligand-mediated activation could be envisaged, for example involving increased expression of the ligand, altered post-translational modification of the ligand, or decreased levels of target cell-expressed ligands for gd T cell inhibitory receptors. Clearly, future studies in this area, guided by the criteria outlined above, may resolve some of these key questions.
Nature of Immune Stimuli for Vd1
Responses Although CMV appears to trigger clonal expansion of Vd1 T cells, the fact that CMV-seronegative adults still frequently harbour major Vd1 T effector populations indicates that other immune stimuli, possibly other infectious challenges, must trigger specific Vd1 responses. Consistent with this, several pathogens have been linked with increased numbers or clonality of Vd2-negative T cells, including HIV [46] , Epstein-Barr virus (EBV) [48, 49] , and other microbial infections [1] . Despite this, the link between a given pathogen infection, specific Vd1 clonal expansion, and an augmented recall response to that challenge warrants further study. Several reasons suggest that the transition from Vd1 T naïve to T effector status accompanying such clonal expansions would increase the speed and potency of effector responses: notably, Vd1 T effector cells express perforin and granzymes, whereas Vd1 T naïve cells do not; moreover, Vd1 T effector cells exhibit enhanced and more rapid production of cytokines and proliferation relative to Vd1 T naïve cells following CD3/CD28 stimulation [38] . In addition, previous studies have highlighted Vd2-negative T effector responses to CMV-infected target cells following CMV infection [27] , alongside an increased proportion of Vd1 T cells bearing an effector phenotype relative to CMVseronegative individuals [29] . However, an increased understanding of how such alterations link with clonotypic changes is needed. Given the diverse stimuli that could underpin the generation of clonotypic Vd1 T effector responses, this will require analysis of human samples before and after relevant infections, and comparison with individuals who either remained uninfected or did not exhibit postinfection clonal expansions. Such analyses will also allow the relative kinetics of the phenotypic transitions and clonal expansion to be assessed.
Evolutionary Advantage of Adaptive MHC-Unrestricted gd T Cell Stress Surveillance
The universal presence of gd T cells in vertebrates suggests that compelling reasons must exist for their evolutionary conservation [1] . In addition to providing semi-invariant gd T cell populations that have evolved recognition modes highly distinct from ab T cell subsets, potentially involving germline-encoded targets, such as BTN3A1 [67, 68] and BTNL/Selection and upkeep of intraepithelial T cells (Skint) family members [12, 69] , it is interesting to consider what evolutionarily advantageous immune functions adaptive gd T cell subsets might alternatively provide. With regards to CMV infection, the only pathogenic challenge currently confirmed as driving the clonotypic expansion of human Vd1 T cells, much evidence supports a role for NK cells [70] and CD8 T cells [71] in anti-CMV immunity. However, CMV has also evolved numerous immune evasion strategies targeted at disrupting essential components of CD8/NK immunosurveillance, including the MHC presentation pathway [72] , and sequestration of ligands for conserved activatory ligands for germline-encoded NKRs, such as natural killer group 2 member D (NKG2D) [70] . Evolution of a stochastically recombined immune receptor repertoire allowing MHC-unrestricted recognition of 'altered/stressed self' via diverse and potentially private gd TCR reactivities to intact cell surface antigens, would likely complement such strategies and may prove more challenging for pathogens to evade. Conceivably, such subsets could also enable direct recognition of foreign pathogen proteins on the surface of infected host cells. Recent data from mouse models suggesting that gd T cells provide as potent protection against CMV as the CD8 T cell compartment [73, 74] are consistent with these ideas; however, further studies are required to understand the immunobiology of the gd subsets involved and the molecular basis of the recognition events in which they are involved.
Concluding Remarks
Recent studies have substantially revised our understanding of Vd1 T cells. The coincident clonal expansion and differentiation of Vd1 T cells not only represent a 'smoking gun' that the gd TCR is likely to be central to their immunobiology, but also lead us to propose that Vd1 function is underpinned by a novel MHC-unrestricted adaptive paradigm. This contrasts with Vg9/Vd2 T cell immunobiology, which appears to be predominantly innate-like, highlighting the coexistence of adaptive and innate-like paradigms within the human gd T cell lineage.
This adaptive perspective for Vd1 T cells prompts a reassessment of previous studies, and also provides an intellectual framework around which future investigations can be designed, which should help answer the many unresolved questions (see Outstanding Questions). Of these, the question of what represent bona fide physiological ligands for Vd1 gd TCRs in the context of this adaptive paradigm is central, but importantly the repertoire and immunophenotype-based observations upon which the paradigm is built suggest objective criteria by which to assess such reactivities and plan future studies. Moreover, there is an expanding evidence base for the importance of Skint/BTN/BTNL molecules in mouse gd T cell development and biology [12, 69, 75] . Understanding the full significance of this family in human gd T cell biology in the context of parallel innate-like and adaptive-like paradigms is another aim.
An improved understanding of human gd T cell biology will hopefully accelerate therapeutic exploitation of their function. Despite limited understanding of gd TCR ligand recognition, there is already substantial therapeutic interest in gd T cells, particularly in the cancer immunotherapy arena, not least due to their MHC-unrestricted recognition of target cells and potent cytotoxic function. In addition, the ability to immunophenotypically delineate Vd1 T naïve from T effector subpopulations should provide a means to probe Vd1 T cell responses against diverse microbial and non-microbial immunological challenges at different life stages, which would
Outstanding Questions
What thymic processes shape the Vd1 repertoire?
How is Vd1 clonal amplification initiated? Does this occur in lymphoid organs or in peripheral tissues and, if so, which factors and/or antigen-presenting cells are involved?
When do adaptive Vd1 responses occur throughout life? Do they compensate for when ab T cell responses are suppressed, such as in neonates or after transplantation?
Aside from CMV, which stress stimuli trigger clonal selection? What is the range of pathogens involved, and which non-microbial stimuli can drive Vd1 responses in vivo?
What is special about clonally expanded Vd1 TCRs? Are they capable of recognising ligands that relate to physiologically relevant stress stimuli and, if so, what are these? Are the ligands private to each individual or public, and how do they relate to each other?
Why are the Vd1 repertoires of some individuals more clonotypically focussed than others? Does this reflect differences in pathogen exposure, or are there 'holes' in the Vd1 repertoires of some individuals with respect to specific stress challenges?
How do the repertoire and immunobiology of Vd1 T cells in solid tissues relate to peripheral blood Vd1 T cells? Do they overlap with adaptive Vd1 subsets in peripheral blood, or are they distinct, and might they also contain semi-invariant populations, as defined in mouse tissue-associated gd T cells?
Is there a role for BTNL molecules (e. g., BTNL3/8) in the development, selection, or antigenic stimulation of the Vd1 T cell compartment? If so, does this involve innate-like or adaptive Vd1 populations?
How phenotypically plastic are Vd1 T cells? Can they be exploited therapeutically, such as in vaccination or adoptive transfer approaches?
represent an important early step along the pathway towards the successful therapeutic exploitation of gd T cell function.
